Form D · Private Equity Fund

Wellington Biomedical Innovation Investors (Cayman) II L.P.

Boston, MA · CIK 0001903359

Offering snapshot reported Jan 6, 2023 · SEC filing

Reported sold: $193M
Investors reported: 24
Minimum accepted: $0
First sale: Jan 10, 2022

What changed?

Latest filing versus its linked predecessor, where available.

Reported investors0 → 24

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Jan 6, 2023	Amendment	$192,515,000	No comparison	24	SEC filing
Jan 7, 2022	Initial	Yet to sell	No comparison	0	SEC filing

Offering details

Securities: Pooled investment fund
Exemptions: 06b, 3C, 3C.7
Duration over one year: Yes
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-428447

THE MANAGEMENT COMPANY OR ITS AFFILIATE IS REQUIRED TO PAY PLACEMENT FEES BASED ON THE AGGREGATE CAPITAL COMMITMENTS OF CERTAIN INVESTORS IN THE FUND.

Sales compensation recipients

Scroll to see all columns →

Recipient	CRD	Associated broker-dealer
WELLINGTON FUNDS DISTRIBUTORS INC.	152768
GOLDMAN SACHS & CO. LLC	361
J.P. MORGAN SECURITIES LLC	79

Source: Form D, filed Jan 6, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

WELLINGTON BIOMEDICAL INNOVATION INVESTORS (CAYMAN) II L.P.

Investment adviser: WELLINGTON ALTERNATIVE INVESTMENTS LLC

Gross asset value: $172M
Beneficial owners: 29
ADV minimum commitment: $1M

Reported in Form ADV on Sep 29, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator INTERNATIONAL FUND SERVICES (N.A.), L.L.C. NEW YORK, New York, United States Investor statements: Yes (provided to all investors) Related to adviser: No

Auditor PRICEWATERHOUSECOOPERS LLP BOSTON, Massachusetts, United States

Custodian STATE STREET BANK AND TRUST COMPANY BOSTON, Massachusetts, United States Related to adviser: No

Marketer GOLDMAN SACHS & CO. LLC NEW YORK, New York, United States Related to adviser: No

Marketer J.P. MORGAN SECURITIES LLC NEW YORK, New York, United States Related to adviser: No

Marketer WELLINGTON FUNDS DISTRIBUTORS INC. BOSTON, Massachusetts, United States Related to adviser: Yes

Provider details

Annual audit: Yes
Prime brokers: No
Custodians: Yes
Administrator other than the adviser: Yes
External marketing: Yes

PRICEWATERHOUSECOOPERS LLP
PCAOB 238

STATE STREET BANK AND TRUST COMPANY
LEI 571474TGEMMWANRLN572

GOLDMAN SACHS & CO. LLC
CRD 361 · SEC 801-16048

J.P. MORGAN SECURITIES LLC
CRD 79 · SEC 801-3702

WELLINGTON FUNDS DISTRIBUTORS INC.
CRD 152768 · SEC 8-68476

Filing source

Form ADV 2130971 · Sep 29, 2026 · Schedule D 7.B.(1), fund 805-6623751456

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
N/A Wellington Alternative Investments Llc	Executive, Promoter
N/A Wellington Management Company Llp	Executive, Promoter
N/A Wellington Management Investment, Inc.	Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:

280 Congress Street
Boston, MA, 02210